Drugs / T-Cell Depleted & CD34+Select/w/StemCell Enriched Product
T-Cell Depleted & CD34+Select/w/StemCell Enriched Product
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00023192 | Aug 2001 → Jun 2004 | chronic granulomatous disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | T-Cell Depleted & CD34+Select/w/StemCell Enriched Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00023192 ↗ |
| Modality | Cell therapy | “donor's stem cells will be infused” NCT00023192 ↗ |